PSYC’s CEO Provides Detailed Update on the State of the Company

Matthew Dunehoo and David delve into an enlightening discussion about the hurdles, victories, and breakthroughs propelling PSYC ahead. They explore how Psychedelic Spotlight is adapting to changes and what these developments signify for stakeholders and the broader community, reaffirming their dedication to advancing psychedelic medicine.